108605
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
超越体重指数：一项关于区域脂肪组织对多囊卵巢综合征的因果效应及介导途径的孟德尔随机化研究
Authors Yang J, Zhang X, Zhang H, Guo X, Ren F, Dong C
Received 9 July 2025
Accepted for publication 15 September 2025
Published 25 September 2025 Volume 2025:17 Pages 3279—3291
DOI https://doi.org/10.2147/IJWH.S552619
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Vinay Kumar
Jing Yang,1 Xihui Zhang,2 Hui Zhang,2 Xiaolu Guo,3 Fengjuan Ren,1 Cui Dong1
1Department of Reproductive Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, People’s Republic of China; 2Department of Reproductive Medicine, Handan Center Hospital, Handan, Hebei Province, People’s Republic of China; 3Gynecological Consultation Room, Handan Center Hospital, Handan, Hebei Province, People’s Republic of China
Correspondence: Cui Dong, Department of Reproductive Medicine, The Fourth Hospital of Hebei Medical University, No. 12 Jiankang Road, Shijiazhuang, 050011, Hebei Province, People’s Republic of China, Tel +86-15633085736, Email 48703923@hebmu.edu.cn
Background: Previous studies suggest that increased body fat is associated with polycystic ovary syndrome (PCOS) risk. Recent evidence highlights that the distribution of adipose tissue may play a more critical role in predicting PCOS risk compared to total fat mass; however, causal relationships remain unclear. This Mendelian randomization (MR) study aimed to investigate the causal associations between body mass index (BMI)-independent regional adipose tissue distribution and PCOS risk.
Methods: Female-specific data on regional adipose tissue depots (n = 19,273), independent of BMI and height, including gluteofemoral adipose tissue (GFAT), abdominal subcutaneous adipose tissue (ASAT), visceral adipose tissue (VAT), and related adipose tissue ratios, were derived from large-scale genome-wide association studies. Independent genetic instruments were selected based on genome-wide significance (P < 5 × 10− 8), and the Steiger test confirmed causal direction. Causal associations were validated through meta-analysis combining discovery and replication PCOS datasets. Additionally, two-step mediation analysis was performed to investigate five potential mediators: sex hormones, lipid metabolism, glucose metabolism, adipose-specific factors, and inflammatory markers.
Results: Genetically predicted higher GFAT volume demonstrated a significant causal protective effect on PCOS risk (OR = 0.845, 95% CI: 0.735– 0.971). This protective effect was predominantly mediated through reductions in fasting insulin (58.37%, 95% CI: 27.66– 89.08%) and leptin (51.75%, 95% CI: 33.54– 75.41%). Other mediators included the homeostasis model assessment of insulin resistance (HOMA-IR; 37.20%), sex hormone-binding globulin (SHBG; 24.74%), bioavailable testosterone (BT; 11.99%), and triglycerides (TG; 9.52%). Additionally, suggestive evidence driven by a single genetic instrument linked higher VAT/ASAT, VAT/GFAT, and ASAT/GFAT ratios to increased PCOS risk (OR > 1). Sensitivity analyses and supplementary methods confirmed the robustness of these findings.
Conclusion: This study provides causal evidence supporting the protective role of GFAT against PCOS and identifies critical metabolic and hormonal pathways as mediators. These results highlight the significance of adipose tissue distribution patterns in the pathogenesis of female endocrine disorders.
Keywords: Mendelian randomization, polycystic ovary syndrome, gluteofemoral adipose tissue, abdominal subcutaneous adipose tissue, visceral adipose tissue
1Department of Reproductive Medicine, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, People’s Republic of China; 2Department of Reproductive Medicine, Handan Center Hospital, Handan, Hebei Province, People’s Republic of China; 3Gynecological Consultation Room, Handan Center Hospital, Handan, Hebei Province, People’s Republic of China
Correspondence: Cui Dong, Department of Reproductive Medicine, The Fourth Hospital of Hebei Medical University, No. 12 Jiankang Road, Shijiazhuang, 050011, Hebei Province, People’s Republic of China, Tel +86-15633085736, Email 48703923@hebmu.edu.cn
Background: Previous studies suggest that increased body fat is associated with polycystic ovary syndrome (PCOS) risk. Recent evidence highlights that the distribution of adipose tissue may play a more critical role in predicting PCOS risk compared to total fat mass; however, causal relationships remain unclear. This Mendelian randomization (MR) study aimed to investigate the causal associations between body mass index (BMI)-independent regional adipose tissue distribution and PCOS risk.
Methods: Female-specific data on regional adipose tissue depots (n = 19,273), independent of BMI and height, including gluteofemoral adipose tissue (GFAT), abdominal subcutaneous adipose tissue (ASAT), visceral adipose tissue (VAT), and related adipose tissue ratios, were derived from large-scale genome-wide association studies. Independent genetic instruments were selected based on genome-wide significance (P < 5 × 10− 8), and the Steiger test confirmed causal direction. Causal associations were validated through meta-analysis combining discovery and replication PCOS datasets. Additionally, two-step mediation analysis was performed to investigate five potential mediators: sex hormones, lipid metabolism, glucose metabolism, adipose-specific factors, and inflammatory markers.
Results: Genetically predicted higher GFAT volume demonstrated a significant causal protective effect on PCOS risk (OR = 0.845, 95% CI: 0.735– 0.971). This protective effect was predominantly mediated through reductions in fasting insulin (58.37%, 95% CI: 27.66– 89.08%) and leptin (51.75%, 95% CI: 33.54– 75.41%). Other mediators included the homeostasis model assessment of insulin resistance (HOMA-IR; 37.20%), sex hormone-binding globulin (SHBG; 24.74%), bioavailable testosterone (BT; 11.99%), and triglycerides (TG; 9.52%). Additionally, suggestive evidence driven by a single genetic instrument linked higher VAT/ASAT, VAT/GFAT, and ASAT/GFAT ratios to increased PCOS risk (OR > 1). Sensitivity analyses and supplementary methods confirmed the robustness of these findings.
Conclusion: This study provides causal evidence supporting the protective role of GFAT against PCOS and identifies critical metabolic and hormonal pathways as mediators. These results highlight the significance of adipose tissue distribution patterns in the pathogenesis of female endocrine disorders.
Keywords: Mendelian randomization, polycystic ovary syndrome, gluteofemoral adipose tissue, abdominal subcutaneous adipose tissue, visceral adipose tissue